MedTrace Logo

mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation

NCT04525222 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 242

Last updated 2024-03-07

Study results available
· View outcomes & findings →

Summary

This phase I trial investigates a new smartphone application (called Actify) for improving population-level smoking cessation and mood management. Actify delivers behavioral activation therapy for depression as part of a smoking cessation intervention and will be compared to another smoking cessation smartphone application that is based on current clinical practice guidelines. Participants will be randomly assigned to receive one of two smartphone applications and accompanying text notifications to help with quitting smoking and improved mood.

Conditions

  • Cigarette Smoking-Related Carcinoma

Interventions

OTHER

Health Promotion and Education

Receive motivational messages and smoking cessation information via text notifications

BEHAVIORAL

Smoking Cessation Intervention (Actify app)

Use Actify app

BEHAVIORAL

Smoking Cessation Intervention (Current Standard Care app)

Use (USCPG) Current Standard Care app

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Jaimee Heffner · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-09
Primary Completion
2022-12-19
Completion
2023-04-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04525222 on ClinicalTrials.gov